Show simple item record

dc.contributor.author
Probst, Philipp
dc.contributor.author
Stringhini, Marco
dc.contributor.author
Ritz, Danilo
dc.contributor.author
Fugmann, Tim
dc.contributor.author
Neri, Dario
dc.date.accessioned
2019-11-04T07:51:19Z
dc.date.available
2019-02-01T04:24:43Z
dc.date.available
2019-02-22T12:57:12Z
dc.date.available
2019-11-01T14:29:09Z
dc.date.available
2019-11-01T15:43:21Z
dc.date.available
2019-11-04T07:51:19Z
dc.date.issued
2019-01
dc.identifier.issn
1078-0432
dc.identifier.issn
1557-3265
dc.identifier.other
10.1158/1078-0432.CCR-18-1728
en_US
dc.identifier.uri
http://hdl.handle.net/20.500.11850/322259
dc.identifier.doi
10.3929/ethz-b-000322259
dc.format
application/pdf
en_US
dc.language.iso
en
en_US
dc.publisher
American Association for Cancer Research
en_US
dc.rights.uri
http://rightsstatements.org/page/InC-NC/1.0/
dc.title
Antibody-based Delivery of TNF to the Tumor Neovasculature Potentiates the Therapeutic Activity of a Peptide Anticancer Vaccine
en_US
dc.type
Journal Article
dc.rights.license
In Copyright - Non-Commercial Use Permitted
dc.date.published
2018-10-16
ethz.journal.title
Clinical Cancer Research
ethz.journal.volume
25
en_US
ethz.journal.issue
2
en_US
ethz.journal.abbreviated
Clin Cancer Res
ethz.pages.start
698
en_US
ethz.pages.end
709
en_US
ethz.size
27 p. submitted version
en_US
ethz.version.deposit
acceptedVersion
en_US
ethz.grant
Understanding and Exploiting the Molecular Targeting of Tumor Neo-vasculature
en_US
ethz.grant
Fulfilling Paul Ehrlich’s Dream: therapeutics with activation on demand
en_US
ethz.identifier.wos
ethz.identifier.scopus
ethz.publication.place
Philadelphia, PA
en_US
ethz.publication.status
published
en_US
ethz.leitzahl
ETH Zürich::00002 - ETH Zürich::00012 - Lehre und Forschung::00007 - Departemente::02020 - Dep. Chemie und Angewandte Biowiss. / Dep. of Chemistry and Applied Biosc.::02534 - Institut für Pharmazeutische Wiss. / Institute of Pharmaceutical Sciences::03463 - Neri, Dario (ehemalig) / Neri, Dario (former)
en_US
ethz.leitzahl.certified
ETH Zürich::00002 - ETH Zürich::00012 - Lehre und Forschung::00007 - Departemente::02020 - Dep. Chemie und Angewandte Biowiss. / Dep. of Chemistry and Applied Biosc.::02534 - Institut für Pharmazeutische Wiss. / Institute of Pharmaceutical Sciences::03463 - Neri, Dario (ehemalig) / Neri, Dario (former)
ethz.grant.agreementno
163479
ethz.grant.agreementno
670603
ethz.grant.fundername
SNF
ethz.grant.fundername
EC
ethz.grant.funderDoi
10.13039/501100001711
ethz.grant.funderDoi
10.13039/501100000780
ethz.grant.program
H2020
ethz.grant.program
Exzellenzbeitrag in Biologie und Medizin (Abteilung III)
ethz.date.deposited
2019-02-01T04:24:45Z
ethz.source
WOS
ethz.eth
yes
en_US
ethz.availability
Open access
en_US
ethz.rosetta.installDate
2019-02-22T12:57:25Z
ethz.rosetta.lastUpdated
2021-02-15T06:32:38Z
ethz.rosetta.versionExported
true
ethz.COinS
ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.atitle=Antibody-based%20Delivery%20of%20TNF%20to%20the%20Tumor%20Neovasculature%20Potentiates%20the%20Therapeutic%20Activity%20of%20a%20Peptide%20Anticancer%20Vaccine&rft.jtitle=Clinical%20Cancer%20Research&rft.date=2019-01&rft.volume=25&rft.issue=2&rft.spage=698&rft.epage=709&rft.issn=1078-0432&1557-3265&rft.au=Probst,%20Philipp&Stringhini,%20Marco&Ritz,%20Danilo&Fugmann,%20Tim&Neri,%20Dario&rft.genre=article&
 Search print copy at ETH Library

Files in this item

Thumbnail

Publication type

Show simple item record